Target intelligence / Profile preview

T helper cell type 1 cytokines

Molecular classification
Other
01

Overview

T helper cell type 1 cytokines" refers to cytokines produced predominantly by Th1 cells, a subset of CD4+ T helper cells. The principal cytokines include interferon-gamma (IFN-γ), interleukin-2 (IL-2), and tumor necrosis factor-alpha (TNF-α)[1][3][4][5][8]. These cytokines play key roles in the immune response against intracellular pathogens such as viruses and certain bacteria by activating macrophages, supporting cytotoxic T cell responses, and promoting inflammation[1][3][4][7]. Key points and reasoning: - This entry is not a canonical target name but a functional label for a cytokine profile. - The principal Th1 cytokines are IFN-γ, IL-2, and TNF-α[1][4][5][8]. Each of those is a well-defined therapeutic target and biological product, but "T helper cell type 1 cytokines" collectively is not a drug target nor a singular protein entity. - For structured database purposes, each cytokine (e.g., "Interferon gamma," "Tumor necrosis factor alpha") should have a separate entry. - Th1 cytokines play crucial roles in cell-mediated immunity and are associated with a range of disease processes, especially autoimmune diseases and chronic inflammation[5][10]. Safety concerns and biomarkers: - Safety concerns, mechanisms, and biomarker functions all pertain to individual cytokines, not the group as a whole. - Therapeutic drugs (like monoclonal antibodies) target individual cytokines (e.g., anti-TNF drugs) but not the cytokine group collectively. Conclusion: The term "T helper cell type 1 cytokines" is overly broad and does not correspond to a specific molecule or canonical therapeutic target, so is_incorrect should be marked as true. For detailed, structured information, use entries for each specific cytokine.

Other names
Th1 cytokinesT helper 1 cytokinescytokines secreted by Th1 cellstype 1 T-helper cell cytokines
02

Biological functions

Immune responseCell-mediated immunityInflammation
03

Disease associations

InfectionInflammationAutoimmune diseaseCancer

Beyond the preview

Go deeper on T helper cell type 1 cytokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T helper cell type 1 cytokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call